What is the role of topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in managing osteoarthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Topical NSAIDs in Managing Osteoarthritis

Topical NSAIDs are strongly recommended as first-line pharmacological treatment for knee osteoarthritis and conditionally recommended for hand osteoarthritis due to their favorable safety profile compared to oral analgesics while providing effective pain relief. 1

Efficacy and Indications

  • Topical NSAIDs should be considered prior to oral NSAIDs for accessible joints, particularly for knee OA (strong recommendation) and hand OA (conditional recommendation) 1
  • Topical NSAIDs provide similar pain relief as oral NSAIDs but with fewer systemic side effects, making them particularly valuable for patients with risk factors for NSAID-related complications 1, 2
  • Topical diclofenac is FDA-approved specifically for the treatment of pain associated with osteoarthritis of the knee 3
  • Topical NSAIDs are not recommended for hip OA due to the depth of the joint beneath the skin surface, which makes topical application unlikely to provide benefit 1

Safety Profile

  • Topical NSAIDs have a superior safety profile compared to oral NSAIDs, with fewer gastrointestinal, cardiovascular, and renal adverse events 1, 4
  • Topical NSAIDs are particularly beneficial for elderly patients (≥75 years) and those with comorbidities or increased risk of systemic NSAID-related complications 4
  • The main side effects of topical NSAIDs are limited to local application site reactions, with systemic adverse events being rare 5

Treatment Algorithm for Osteoarthritis

  1. First-line approach: Begin with core treatments for all patients:

    • Regular exercise programs (walking, strengthening, aquatic) 6
    • Weight loss if overweight or obese 6
    • Self-management education 6
  2. First-line pharmacological treatment:

    • For knee OA: Topical NSAIDs (strong recommendation) 1
    • For hand OA: Topical NSAIDs (conditional recommendation) 1
    • For hip OA: Consider oral NSAIDs as topical preparations are unlikely to be effective 1
  3. If inadequate response to topical NSAIDs:

    • Progress to oral NSAIDs at the lowest effective dose for the shortest possible duration 1
    • Consider paracetamol (acetaminophen) if NSAIDs are contraindicated 1
  4. For persistent symptoms or flares:

    • Consider intra-articular corticosteroid injections for knee and hip OA (strong recommendation) and hand OA (conditional recommendation) 1

Practical Considerations

  • When selecting a topical NSAID, consider formulation properties as there is heterogeneity among products regarding absorption and bioavailability 4
  • Diclofenac formulations have shown good efficacy with evidence of accumulation in synovial tissues 4
  • For patients with multiple affected joints, systemic pharmacological treatment may be more practical than topical NSAIDs 1
  • Topical NSAIDs should be applied to clean, dry skin and patients should wash hands after application unless the hands are the treated joint 2
  • Practical considerations such as frequent hand washing may limit the use of topical NSAIDs for hand OA 1

Comparative Efficacy

  • Multiple head-to-head trials have demonstrated that topical NSAIDs provide at least equivalent analgesia, improved physical function, and reduced stiffness compared to oral NSAIDs in osteoarthritis 2
  • Studies comparing diclofenac gel with ketoprofen gel showed equal efficacy between these topical NSAID formulations 7
  • Topical capsaicin is conditionally recommended for knee OA but conditionally recommended against for hand OA due to small effect sizes and risk of eye contamination 1

By following this evidence-based approach to incorporating topical NSAIDs into osteoarthritis management, clinicians can provide effective pain relief while minimizing systemic adverse effects, particularly in vulnerable populations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Osteoarthritis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Early Potent NSAIDs for Non-Surgical Musculoskeletal Injuries

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.